Company Research Report: Metro Infectious Disease Consultants (MIDC)
Company Overview
Name: Metro Infectious Disease Consultants (MIDC)
Mission: Metro Infectious Disease Consultants aims to deliver the highest quality of patient care by providing state-of-the-art infectious disease services and infusion therapies across the nation.
Founded: 1994
Founders:
- Russ Petrak
- Bob Fliegelman
- Dave Hines
Key People:
- Founding Partners: Dan Hirsch, Rodica Dumitru, Dave Waitley
Headquarters: No specific headquarters location found.
Number of Employees: Over 100 infectious disease physicians, 57 advanced practice providers, 80 nurses, and 20 pharmacists.
Revenue: No information is available.
Known For: MIDC is renowned for being the nation's largest infectious disease group, providing both inpatient and outpatient consultation, Outpatient Parenteral Antibiotic Therapy (OPAT), and serving multiple states with a strategic focus on quality healthcare delivery to avoid hospitalization.
Products
Hospital Avoidance Program
- Description: This program offers rapid-response evaluation and treatment for acute conditions like cellulitis, abscesses, urinary tract infections, among others.
- Key Features:
- Same-day service.
- Aims to avoid costs, hassle, and stress of hospitalization.
- Specialized outpatient care.
Infusion Center Services
- Description: A range of biological infusions provided in a specialized and comfortable setting to meet diverse patient needs.
- Key Features:
- Services available seven days a week.
- Includes therapies like Colony-stimulating factors, Fabrazyme, IVIG, and Total Parenteral Nutrition.
- Pediatric infusion services.
- Comprehensive care management including appointment coordination, treatment administration, and insurance billing.
Recent Developments
Recent Developments in the Company:
- Expanded to multiple states beyond the initial Chicago focus, now operating in locations including Alabama, Arizona, Georgia, Illinois, Kansas, Michigan, and Missouri.
New Products Launched: No specific new products information is available.
New Features Added to Existing Products: No specific new features information is available.
New Partnerships: No information is available.
Note: This report contains detailed findings specific to the Metro Infectious Disease Consultants based on the provided data. Aspects not mentioned were either not applicable or information was not available at the time of this report creation.
